Dr. Blasi completed her undergraduate and Ph.D. studies in Italy at the Sapienza University in Rome. She moved to Duke for a postdoctoral position in Mary Klotman’s laboratory at the Duke Human Vaccine Institute. Her research interests focus on two major priorities in the HIV-1 field: vaccine development and latent reservoirs/ cure studies.
Dr. Blasi’s work encompasses several aspects of HIV-1 research, ranging from designing and testing a novel vaccine platform based on an integrase defective lentiviral vector (IDLV) in non-human primates (NHP), to the study of the kidney as a non-canonical reservoir for HIV-1.
Education and Training
- Ph.D., La Sapienza University of Rome (Italy), 2012